Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco, Guillermo
Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials. [electronic resource] - Clinical genitourinary cancer 12 2017 - 652-660.e1 p. digital
Publication Type: Journal Article
1938-0682
10.1016/j.clgc.2017.03.004 doi
Adult
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--pathology
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Kidney Neoplasms--pathology
Male
Middle Aged
Nephrectomy--methods
Regression Analysis
Retrospective Studies
Treatment Outcome
Young Adult
Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials. [electronic resource] - Clinical genitourinary cancer 12 2017 - 652-660.e1 p. digital
Publication Type: Journal Article
1938-0682
10.1016/j.clgc.2017.03.004 doi
Adult
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--pathology
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Kidney Neoplasms--pathology
Male
Middle Aged
Nephrectomy--methods
Regression Analysis
Retrospective Studies
Treatment Outcome
Young Adult